Ignite Creation Date:
2024-05-06 @ 9:58 AM
Last Modification Date:
2024-10-26 @ 12:22 PM
Study NCT ID:
NCT03123796
Status:
COMPLETED
Last Update Posted:
2017-12-27
First Post:
2017-04-19
Brief Title:
Effects of Proton Pump Inhibitors on Kidney Transplant Recipients
Sponsor:
Istanbul University
Organization:
Istanbul University
Study Overview
Official Title:
Effects of Proton Pump Inhibitors on Kidney Transplant Recipients
Status:
COMPLETED
Status Verified Date:
2017-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Use of proton pump inhibitors PPIs is quite common among renal transplant recipients and reduced kidney functions and hypomagnesemia with the use of PPIs have been reported In this study investigation of the effects of PPI use on the outcome of kidney transplant recipients is aimed
Detailed Description:
Use of proton pump inhibitors PPIs is frequent among renal transplant recipients due to the common use of glucocorticoids in immunosuppresive regimens after transplantation Reduced kidney functions and hypomagnesemia with the use of PPIs have been reported in various patient populations However few studies examined the effects of PPIs on kidney transplant recipients Therefore the aim of this study is to investigate the effects of PPI andor histamine H2 receptor antagonist use on serum magnesium levels allograft functions and survival in kidney transplant recipients
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None